BRAIN BIOTECH AG (BNN.DE) Stock Analyst Ratings
Europe - Frankfurt Stock Exchange - FRA:BNN - DE0005203947 - Common Stock
2.28 EUR
-0.06 (-2.56%)
ChartMill assigns a Buy % Consensus number of 87% to BNN.DE. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 6.12. This target is 168.42% above the current price.
- BNN.DE was analyzed by 9 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about BNN.DE.
- In the previous month the buy percentage consensus was at a similar level.
- BNN.DE was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-29 | BAADER HELVEA EQUITY RESEARCH | Maintains | Buy -> Buy |
| 2023-08-29 | WARBURG RESEARCH GMBH | Maintains | Buy -> Buy |
BRAIN BIOTECH AG / BNN.DE FAQ
Can you provide the average price target for BRAIN BIOTECH AG stock?
9 analysts have analysed BNN.DE and the average price target is 6.12 EUR. This implies a price increase of 168.42% is expected in the next year compared to the current price of 2.28.
What is the consensus rating for BNN stock?
The consensus rating for BRAIN BIOTECH AG (BNN.DE) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.